BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37738489)

  • 21. Changing trends in melanoma treatment and the expanding role of the dermatologist.
    Brown MD; Johnson TM; Swanson NA
    Dermatol Clin; 1991 Oct; 9(4):657-67. PubMed ID: 1934641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Melanoma: Geographic Trends in Incidence, Stage, and Mortality in the United States.
    Borad A; Deianni E; Peña K; Burjonrappa S
    J Surg Res; 2023 Oct; 290():215-220. PubMed ID: 37285703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does shave biopsy accurately predict the final breslow depth of primary cutaneous melanoma?
    Moore P; Hundley J; Hundley J; Levine EA; Williford P; Sangueza O; McCoy T; Shen P
    Am Surg; 2009 May; 75(5):369-73; discussion 374. PubMed ID: 19445285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist.
    Pennie ML; Soon SL; Risser JB; Veledar E; Culler SD; Chen SC
    Arch Dermatol; 2007 Apr; 143(4):488-94. PubMed ID: 17438181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.
    Kang JC; Wanek LA; Essner R; Faries MB; Foshag LJ; Morton DL
    J Clin Oncol; 2005 Jul; 23(21):4764-70. PubMed ID: 16034052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual melanoma in wide local excision specimens after 'complete' excision of primary cutaneous in situ and invasive melanomas.
    Jackett LA; Satgunaseelan L; Roper E; Lo SN; Thompson JF; Scolyer RA
    Pathology; 2022 Feb; 54(1):71-78. PubMed ID: 34392983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demographics, Risk Factors, and Incidence of Melanoma in Patients in the New England VA Healthcare system.
    Bae E; Leone D; Konnikov N; Mahalingam M
    Mil Med; 2019 May; 184(5-6):e408-e416. PubMed ID: 30395278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asthma Surveillance - United States, 2006-2018.
    Pate CA; Zahran HS; Qin X; Johnson C; Hummelman E; Malilay J
    MMWR Surveill Summ; 2021 Sep; 70(5):1-32. PubMed ID: 34529643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Access to Care Associated With Stage at Presentation and Survival for Melanoma Patients?
    Pitre LD; Linford G; Pond GR; McWhirter E; Seow H
    J Cutan Med Surg; 2019; 23(6):586-594. PubMed ID: 31462069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node biopsy in elderly irish patients with malignant melanoma.
    Moran DE; Smith MJ; O'Sullivan MJ; Bannon H; Crotty TB; Collins CD; Skehan SJ; O'Higgins N; McDermott EW; Evoy D; Hill AD
    Ir Med J; 2007 Apr; 100(4):422-4. PubMed ID: 17566474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tattoo Pigment within Regional Lymph Nodes Mimicking Cutaneous Melanoma Metastasis.
    Dujmović A; Jurišić N; Mance M; Bulić K; Vrbanović Mijatović V; Mijatović D
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):47-48. PubMed ID: 32650854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of melanoma features and their relationship with nodal disease: the importance of the pathological report.
    Bertolli E; de Macedo MP; Pinto CA; Damascena AS; Molina AS; Ueno PS; Duprat Neto JP
    Tumori; 2015; 101(5):501-5. PubMed ID: 25983100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.
    Mills JK; White I; Diggs B; Fortino J; Vetto JT
    Am J Surg; 2013 May; 205(5):585-90; discussion 590. PubMed ID: 23592167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and pathological features of acral melanoma in a South African population: A retrospective study.
    De Wet J; Tod B; Visser WI; Jordaan HF; Schneider JW
    S Afr Med J; 2018 Aug; 108(9):777-781. PubMed ID: 30182904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compounding Benefits of Sentinel Lymph Node Biopsy for Perineal Melanoma: A Population-Based Retrospective Cohort Analysis.
    Patel RA; Patel PD; Ashack K; Borrelli MR; Trickey A; Wan DC
    Ann Plast Surg; 2020 May; 84(5S Suppl 4):S257-S263. PubMed ID: 32282396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining palliative care program use and place of death in rural and urban contexts: a Canadian population-based study using linked data.
    Lavergne MR; Lethbridge L; Johnston G; Henderson D; D'Intino AF; McIntyre P
    Rural Remote Health; 2015; 15(2):3134. PubMed ID: 26103433
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.